ArticleMolecules (Basel, Switzerland)2022

Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.

Iwona Karwaciak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.